What strategies should be used when treating CKD patients with BP-lowering drugs?
When treating CKD patients with BP-lowering drugs, it is recommended to individualize BP targets and agents according to age, co-existent cardiovascular disease and other co-morbidities, risk of progression of CKD, presence or absence of retinopathy (in CKD patients with diabetes), and tolerance of treatment. Additionally, it is important to inquire about postural dizziness and to check for postural hypotension regularly.